It's been a year since Mat had surgery to remove a dozen or so tumors from his liver. We were hoping the surgery would cure him from cancer, but we got some disappointing news on Friday (disappointing being the understatement of the century).
His lastest CT scans showed some small tumors in his liver, plus indications of cancer in his lymph system. Another surgery seems to be out of the question, and Mat exhausted the standard chemotherapy treatments last summer, which didn't work very well.
All is not lost, however! There is a clinical trial starting in a month or so that Mat's oncologist, Dr. "call me Dave" Ryan, thinks he may be a good candidate for. I have remarkably low listening comprehension skills during these visits with Dave, so I don't know much about it other than it's a targeted therapy (meaning limited side effects, among other things) in the pipeline at GlaxoSmithKline.
Here's one for the pharmaceutical industry: Go Glaxo!